WHO starts initiative for Vaccine Research that facilitates research and development (R&D) against microorganisms with significant economic burden and disease, with a particular focus on low and middle income countries. Our activities span the following areas:
In the past days, the process of vaccine development occur through a series of steps that take a long period of time or many years. Now, in given the urgent need for COVID-19 vaccines, uncommon financial investments and scientific collaborations are changing how vaccines are developed.
Title : Evaluating community-based vaccine initiatives with power BI
Carly Contri, American Academy of Pediatrics, United States
Title : The power of cultural validation when empowering community immunity
Julissa Soto, Julissa Soto Latino Health Equity Consulting, United States
Title : High prevalence of zero-dose children in underserved and special setting populations in Ethiopia using a generalize estimating equation and concentration index analysis.
Gashaw Andargie Biks, Project HOPE, Ethiopia
Title : Your vaccine attitude determines your altitude. What are the determinants of attitudes toward vaccination
Vincenzo Alfano, University of Napoli Parthenope, Italy
Title : Current Investments and Future Directions of Biomedical Advanced Research and Development Authority’s CBRN Vaccines Portfolio
Lindsay Parish, BARDA, United States
Title : Evaluation of vaccine preventable disease VPD surveillance system in Haryana state, India.
Prasoon Sheoran, Directorate of Health and Family Welfare, India
Title : Adaptation of local rabies virus isolates to high growth titer to develop vaccine strain in Ethiopia
Abebe Aga, Armauer Hansen Research Institute, Ethiopia
Title : Antibiotic resistance present situation in Bangladesh at different districts
Ismail Hossain, Globe Biotech, Bangladesh
Title : Spatial distribution of zero-dose children in Ethiopia: Evidence for a targeted intervention from a large-scale evaluation survey
Fisseha Shiferie Tadesse, Project HOPE, Ethiopia
Title : Impact of vaccination on the risk of severe forms of COVID -19 among elderly patients hospitalized in a Tunisian university hospital
Souhir Ayadi, Faculty of Medicine, Tunisia